United Kingdom · Series B startup

Who invested in Holiferm

5 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 1 month ago

Funding summaryUpdated 31 Oct 2026

$51Mraised across 5 rounds since 2021, from 5 sources

$174KRound$9.5MSeries A$2.7MSeries A$23MSeries B$16MSeries B
Latest round
Series B, $16MSept 2026
Biggest round
$23MSeries B · Dec 2023
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202120222023202420252026
$174KRound$9.5MSeries A$2.7MSeries A$23MSeries B$16MSeries B
First round
Round, $174K
Apr 2021
Biggest round
$23M
Series B · Dec 2023
Usual gap between rounds
14 months
the median of 4

The rounds

  1. Sept 2026
    Series B$16M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  2. Dec 2023
    Series B$23M

    No investor was named in the report.

    Source recorded

  3. Sept 2022
    Series A$2.7M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  4. Sept 2021
    Series A$9.5M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  5. Apr 2021
    Round$174K

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

Funding filed with regulators

Holiferm filed 7 raises, $51M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Sept 2026$16MUK share allotment
  2. Sept 2023$3.0MUK share allotment
  3. Sept 2023$20MUK share allotment
  4. Sept 2022$2.7MUK share allotment
  5. Nov 2021$2.4MUK share allotment
  6. Sept 2021$7.0MUK share allotment
  7. Apr 2021$174KUK share allotment

Founders and team

From Holiferm's own website: 2 founders, 14 on the team.

James WinterburnCo-founder & Chief Scientific Officer
Ben DolmanCo-founder & Director
  • Charles DimmlerCEO
  • Richard LockCOO
  • Clare WalkerHead of Global Regulations and Product Safety
  • Karl WilliamsHead of EHS
  • Owen ThreadgoldHead of Projects
  • Alice RobinsonOperations Director
  • Beth FosterFinance Director
  • Carolyn FritzNon-Executive Director
  • Jack SeneProcess Engineering Manager
  • Joana PereiraProduct Sales Team Lead
  • Lisa FoleyProduction Ops Manager
  • Lynne WebsterPeople & Culture Director
  • Sid PalmerSupply Chain Manager
  • Tom PallettCustomer Excellence Team Lead

Quick answers about Holiferm

How much has Holiferm raised?

Holiferm has raised $51M across 5 rounds since 2021.

When did Holiferm last raise?

Holiferm's most recent round was a Series B of $16M in Sept 2026.

What was Holiferm's biggest round?

Holiferm's largest round on record is $23M (Series B), in Dec 2023.

What stage is Holiferm at?

Holiferm's latest named round is a Series B, in Sept 2026.

Where is Holiferm based?

Holiferm is based in the United Kingdom.

Companies like Holiferm

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.